Literature DB >> 14327272

STUDIES WITH ETHYL CHLOROPHENOXYISOBUTYRATE (CLOFIBRATE).

D L AZARNOFF, D R TUCKER, G A BARR.   

Abstract

Entities:  

Keywords:  ANTICHOLESTEREMIC AGENTS; BLOOD CHOLESTEROL; BLOOD LIPIDS; BUTYRATES; CARBON DIOXIDE; CHOLESTEROL; EXPERIMENTAL LAB STUDY; GLYCERIDES; HEPATOMEGALY; LIPID METABOLISM; LIVER FUNCTION; MEVALONIC ACID; ORGAN WEIGHT; PERFUSION; PHARMACOLOGY; PHOSPHOLIPIDS; RATS; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1965        PMID： 14327272     DOI： 10.1016/0026-0495(65)90111-3

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  19 in total

1.  Inhibition of hormone-stimulated lipolysis by clofibrate. A possible mechanism for its hypolipidemic action.

Authors:  M A D'Costa; A Angel
Journal:  J Clin Invest       Date:  1975-01       Impact factor: 14.808

Review 2.  A review of studies on the mode of action of clofibrate and betabenzalbutyrate.

Authors:  H J Fallon; L L Adams; R G Lamb
Journal:  Lipids       Date:  1972-02       Impact factor: 1.880

3.  Confusion with clofibrate.

Authors: 
Journal:  Br Med J       Date:  1972-06-03

4.  Effects of Su-13437, a new hypolipidemic drug, upon synthesis in vivo of hepatic and carcass total fatty acids and total cholesterol.

Authors:  R J Cenedella
Journal:  Lipids       Date:  1971-07       Impact factor: 1.880

5.  Microbodies in experimentally altered cells. V. Histochemical and cytochemical studies on the livers of rats and acatalasemic (Csb) mice treated with CPIB.

Authors:  J Reddy; S Bunyaratvej; D Svoboda
Journal:  Am J Pathol       Date:  1969-09       Impact factor: 4.307

6.  Bile formation and biliary lipid composition under the influence of clofibrate and phenobarbital pretreatment in the rat.

Authors:  K Kutz; A Schulte; C Just; H Lindstaedt; B Reiter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-08       Impact factor: 3.000

7.  [Comparative ultrastructural-morphometric studies on parenchymatic liver cells in Wistar rats (Rattus norwegicus) and desert rats (Meriones crassus) after a single dose of clofibrate].

Authors:  U N Riede; C Ettlin; R von Allmen; H P Rohr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

8.  Effect of halofenate and clofibrate on growth and lipid synthesis in Saccharomyces cerevisiae.

Authors:  M D Greenspan; J I Germershausen
Journal:  J Bacteriol       Date:  1973-02       Impact factor: 3.490

9.  Rapid purification of cytosolic epoxide hydrolase from normal and clofibrate-treated animals by affinity chromatography.

Authors:  G D Prestwich; B D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

10.  Inhibition of hepatic triglyceride formation by clofibrate.

Authors:  L L Adams; W W Webb; H J Fallon
Journal:  J Clin Invest       Date:  1971-11       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.